Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease

Epidemiology and Psychiatric Sciences

Volumn 28, Issue 3, 2019, Pages 333-342

  Marrie, R A ^a   Walld, R ^a   Bolton, J M ^a   Sareen, J ^a   Walker, J R ^a   Patten, S B ^b   Singer, A ^a   Lix, L M ^a   Hitchon, C A ^a   El Gabalawy, R ^a   Katz, A ^a   Fisk, J D ^c   Bernstein, C N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cohort; epidemiology; inflammatory disease; psychiatry

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIPLE SCLEROSIS; ONSET AGE; POPULATION RESEARCH; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SEX DIFFERENCE; MANITOBA; MIDDLE AGED; TRENDS;

ADULT; ARTHRITIS, RHEUMATOID; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MANITOBA; MENTAL DISORDERS; MIDDLE AGED; MULTIPLE SCLEROSIS; RISK FACTORS;

EID: 85033390453     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796017000579     Document Type: Article

References (44)

1. Alamanos Y, Voulgari PV, Drosos AA (2006). Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: A systematic review. Seminars in Arthritis and Rheumatism 36, 182-188.
2. Ang DC, Choi H, Kroenke K, Wolfe F (2005). Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. Journal of Rheumatology 32, 1013-1019.
3. Berger JR, Pocoski J, Preblick R, Boklage S (2013). Fatigue heralding multiple sclerosis. Multiple Sclerosis Journal 19, 1526-1532.
4. Berk M, Williams L, Jacka F, O'Neil A, Pasco J, Moylan S, Allen N, Stuart A, Hayley A, Byrne M, Maes M (2013). So depression is an inflammatory disease, but where does the inflammation come from BMC Medicine 11, 200.
5. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A (1999). Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: A population-based study. American Journal of Epidemiology 149, 916-924.
6. Bernstein CN, Longobardi T, Finlayson G, Blanchard JF (2012). Direct medical cost of managing IBD patients: A Canadian population-based study. Inflammatory Bowel Diseases 18, 1498-1508.
7. Byatt N, Rothschild AJ, Riskind P, Ionete C, Hunt AT (2011). Relationships between multiple sclerosis and depression. The Journal of Neuropsychiatry and Clinical Neurosciences 23, 198-200.
8. Canadian Institute for Health Information (2007). The Burden of Neurological Diseases, Disorders and Injuries in Canada. Ottawa.
9. Chateau D, Metge C, Prior H, Soodeen RA (2012). Learning from the census: The Socio-economic Factor Index (SEFI) and health outcomes in Manitoba. Canadian Journal of Public Health 103, S23-S27.
10. Chiu C-J., Hsu Y-C., Tseng S-P. (2016). Psychological prognosis after newly diagnosed chronic conditions: socio-demographic and clinical correlates. International Psychogeriatrics, 1-12.
11. Cohen S, Janicki-Deverts D, Doyle WJ, Miller GE, Frank E, Rabin BS, Turner RB (2012). Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proceedings of the National Academy of Sciences of the United States of America 109, 5995-5999.
12. EatonWW, Pedersen MG, Nielsen PR, Mortensen PB (2010). Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disorders 12, 638-646.
13. Faust AH, Halpern LF, Danoff-Burg S, Cross RK (2012). Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life. Gastroenterology & Hepatology (New York) 8, 173-181.
14. Hauser W, Janke KH, Klump B, Hinz A (2011). Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflammatory Bowel Disease 17, 621-632.
15. Health Canada (2003). Arthritis in Canada: An Ongoing Challenge. Health Canada: Ottawa.
16. Hitchon CA, Khan S, Elias B, El-Gabalawy HS, Katz A, Peschken CA (2014). First Nations persons have anincreased risk of developing rheumatoid arthritis with an early onset age but are seen less frequently by rheumatologists: A population based study. In ACR/ARHP Annual Meeting. American College of Rheumatology: Boston, MA.
17. Hoang H, Laursen B, Stenager EN, Stenager E (2016). Psychiatric co-morbidity in multiple sclerosis: The risk of depression and anxiety before and after MS diagnosis. Multiple Sclerosis Journal 22, 347-353.
18. Irwin MR, Miller AH (2007). Depressive disorders and immunity: 20 years of progress and discovery. Brain, Behavior and Immunity 21, 374-383.
19. Janssens ACJW, van Doorn PA, de Boer JB, van der Meché FGA, Passchier J, Hintzen RQ (2003). Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurologica Scandinavica 108, 389-395.
20. Kurina LM, Goldacre MJ, Yeates D, Gill LE (2001). Depression and anxiety in people with inflammatory bowel disease. Journal of Epidemiology and Community Health 55, 716-720.
21. Lawrence D, Kisely S (2010). Inequalities in healthcare provision for people with severe mental illness. Journal of Psychopharmacology 24, 61-68.
22. Logan I, Bowlus CL (2010). The geoepidemiology of autoimmune intestinal diseases. Autoimmunity Reviews 9, A372-A378.
23. Marrie RA, Yu N, Blanchard JF, Leung S, Elliott L (2010). The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 74, 465-471.
24. Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Evans C, Wolfson C, Svenson LW, Tremlett H, Blanchard JF, Patten SB (2013). Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurology 13, 16.
25. Marrie RA, Elliott L, Marriott J, Cossoy M, Blanchard J, Leung S, Yu N (2015a). Effect of comorbidity on mortality in multiple sclerosis. Neurology 85, 240-247.
26. Marrie RA, Fisk JD, Tremlett H, Wolfson C, Warren S, Tennakoon A, Leung S, Patten SB (2015b). Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology 85, 1972-1979.
27. Marrie RA, Walker JR, Graff LA, Lix LM, Bolton JM, Nugent Z, Targownik LE, Bernstein CN (2016). Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease. Journal of Psychosomatic Research 89, 107-113.
28. Matcham F, Rayner L, Steer S, Hotopf M (2013). The prevalence of depression in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatology 52, 2136-2148.
29. Mitchell AJ, Benito-León J, González J-MM, Rivera-Navarro J (2005). Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. The Lancet Neurology 4, 556-566.
30. Mok C, Lok E, Cheung E (2012). Concurrent psychiatric disorders are associated with significantly poorer quality of life in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 41, 253-259.
31. Nair GV, Gurbel PA, O'Connor CM, GattisWA, Murugesan SR, Serebruany VL (1999). Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors. American Journal of Cardiology 84, 321-323.
32. Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O (2013). Neuroinflammation and psychiatric illness. Journal of Neuroinflammation 10, 43.
33. Pearlman DM, Najjar S (2014). Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Schizophrenia Research 157, 249-258.
34. Persson LO, Larsson BM, Nived K, Eberhardt K (2005). The development of emotional distress in 158 patients with recently diagnosed rheumatoid arthritis: A prospective 5year followup study. Scandinavian Journal of Rheumatology 34, 191-197.
35. Pugliatti M, Sotgiu S, Rosati G (2002). The worldwide prevalence of multiple sclerosis. Clinical Neurology and Neurosurgery 104, 182-191.
36. Rosenblat JD, McIntyre RS (2015). Are medical comorbid conditions of bipolar disorder due to immune dysfunction Acta Psychiatrica Scandinavica 132, 180-191.
37. Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos G (2004). Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life. The Journal of Rheumatology 31, 58-65.
38. Stetler C, Miller GE (2011). Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosomatic Medicine 73, 114-126.
39. Vieira MMM, Ferreira TB, Pacheco PAF, Barros PO, Almeida CRM, Araújo-Lima CF, Silva-Filho RG, Hygino J, Andrade RM, Linhares UC, Andrade AFB, Bento CAM (2010). Enhanced Th17 phenotype in individuals with generalized anxiety disorder. Journal of Neuroimmunology 229, 212-218.
40. Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L, Rawsthorne P, Miller N, Rogala L, McPhail CM, Bernstein CN (2008). The Manitoba IBD cohort study: A population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. American Journal of Gastroenterology 103, 1989-1997.
41. Wang Q, Yang C, Gelernter J, Zhao H (2015). Pervasive pleiotropy between psychiatric disorders and immune disorders revealed by integrative analysis of multiple GWAS. Human Genetics 134, 1195-1209.
42. Wang S-L, Chang C-H, Hu L-Y, Tsai S-J, Yang AC, You Z-H (2014). Risk of developing depressive disorders following rheumatoid arthritis: A nationwide population-based study. PLoS ONE 9, e107791.
43. WHO Collaborating Centre for Drug Statistics Methodology (2012). Guidelines for ATC Classification and DDD Assignment 2013. Oslo.
44. Yeragani VK, Pohl R, Jampala VC, Balon R, Ramesh C, Srinivasan K (2000). Increased QT variability in patients with panic disorder and depression. Psychiatry Research 93, 225-235.